News and Announcements
Proteomics and Linear Partner in Testing and Clinical Trials
- Published November 16, 2016 2:10PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
15th November 2016, ASX Announcement
Medical technology company Proteomics International Laboratories Ltd (ASX: PIQ) (PILL) and clinical trial specialists Linear Clinical Research Ltd (Linear) are set to offer a combined advanced analytical testing and clinical trial package from January 2017.
- PILL and Linear sign partnership deal to offer a comprehensive analytical testing and clinical trial package
- Potential to double PILL’s analytical services revenue and break new ground in companion diagnostics
- Partnership to target the fast-growing biopharmaceuticals and oncology markets
- New service to commence January 2017
To view the full announcement, please click on the button below.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
